Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 18/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7814249 | 0.90 | HTR1A (0.58) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7962445 | 0.85 | HTR1A (0.42) | HTR1ASLC6A4 | |
| SCHEMBL7965744 | 0.83 | HTR1A (0.36) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7965737 | 0.83 | HTR1A (0.41) | HTR1ASLC6A4ADRB2ADRB1 | |
| SCHEMBL7953370 | 0.83 | HTR1A (0.56) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7887623 | 0.82 | ABCB1 (0.61) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL5584644 | 0.82 | HTR1A (0.59) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7964959 | 0.82 | HTR1A (0.69) | HTR1ASLC6A4ADRB2ADRB1ADRB3 | |
| SCHEMBL7953974 | 0.81 | HTR1A (0.41) | HTR1ASLC6A4ADRB1CYP1A2CYP2C19 | |
| SCHEMBL7965451 | 0.79 | SMN1; SMN2 (0.55) | HTR1ACYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6242450-B1 | SUBSTITUTED PIPERIDINES | ELI LILLY AND COMPANY | 2001-06-05 | — | — | US | disclosed |
| EP-0976746-A1 | 5-HT1F antagonists | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0976747-A2 | Use of 5HT-1F receptor antagonists for treating anxiety disorders | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |